• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma


15.1600 USD 0.0300 0.20%

As of 20:10:00 ET on 10/01/2014.

Snapshot for Depomed Inc (DEPO)

Open: 15.1400 Day's Range: 14.6800 - 15.2700 Volume: 1,426,381
Previous Close: 15.1900 52wk Range: 6.9500 - 15.5100 1-Yr Rtn: +98.43%

Stock Chart for DEPO

No chart data available.
  • DEPO:US 15.1600
  • 1D
  • 1M
  • 1Y
Interactive DEPO Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for DEPO

Current P/E Ratio (ttm) 11.3039
Estimated P/E(12/2014) 85.1685
Relative P/E vs. SPX 0.6402
Earnings Per Share (USD) (ttm) 1.3411
Est. EPS (USD) (12/2014) 0.1780
Est. PEG Ratio -
Market Cap (M USD) 888.16
Shares Outstanding (M) 58.59
30 Day Average Volume 1,375,089
Price/Book (mrq) 4.9401
Price/Sale (ttm) 3.9210
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/05/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for DEPO

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for DEPO

DepoMed, Inc. develops new and proprietary oral drug delivery technologies. The Company has developed a system designed to be retained in the stomach for an extended period of time while it delivers the incorporated drug or drugs. DepoMed has also developed a system designed to reduce gastrointestinal irritation.

James A Schoeneck "Jim"President/CEOAugust J MorettiSenior VP/CFO/Investor Relations
Richard Scott ShivelySenior VP/Chief Commercial OfcrSrinivas G RaoSenior VP/Chief Medical Officer
More Company Profile & Key Executives for DEPO

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil